Yuri Yoshida

883 total citations
33 papers, 598 citations indexed

About

Yuri Yoshida is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Yuri Yoshida has authored 33 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 6 papers in Physiology. Recurrent topics in Yuri Yoshida's work include Total Knee Arthroplasty Outcomes (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Asthma and respiratory diseases (4 papers). Yuri Yoshida is often cited by papers focused on Total Knee Arthroplasty Outcomes (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Asthma and respiratory diseases (4 papers). Yuri Yoshida collaborates with scholars based in Japan, United States and United Kingdom. Yuri Yoshida's co-authors include Lynn Snyder‐Mackler, Ryan L. Mizner, Dan K. Ramsey, Robin L. Marcus, Paul C. LaStayo, Joseph Zeni, Christopher L. Peters, Whitney Meier, Akihiko Oka and Muyiwa Awoniyi and has published in prestigious journals such as Gastroenterology, Biochemical and Biophysical Research Communications and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Yuri Yoshida

29 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuri Yoshida Japan 11 387 160 86 73 67 33 598
Lee Breakwell United Kingdom 11 529 1.4× 75 0.5× 103 1.2× 59 0.8× 19 0.3× 26 936
Jayesh Trivedi United Kingdom 12 609 1.6× 142 0.9× 114 1.3× 117 1.6× 22 0.3× 33 1.1k
Lei Ma China 19 583 1.5× 137 0.9× 70 0.8× 92 1.3× 27 0.4× 48 1.0k
Baoge Liu China 14 440 1.1× 102 0.6× 25 0.3× 69 0.9× 26 0.4× 46 624
Lea Niemitukia Finland 11 334 0.9× 139 0.9× 206 2.4× 62 0.8× 99 1.5× 19 821
Akinori Kaneguchi Japan 11 306 0.8× 69 0.4× 74 0.9× 72 1.0× 24 0.4× 68 476
Yoshimoto Ishikawa Japan 21 1.1k 2.9× 106 0.7× 31 0.4× 55 0.8× 22 0.3× 50 1.4k
P. Marks Canada 15 386 1.0× 71 0.4× 78 0.9× 29 0.4× 65 1.0× 30 635
Deniz Konya Türkiye 19 542 1.4× 36 0.2× 73 0.8× 69 0.9× 76 1.1× 93 1.0k
Alice S. Ferng United States 10 172 0.4× 65 0.4× 28 0.3× 72 1.0× 38 0.6× 18 460

Countries citing papers authored by Yuri Yoshida

Since Specialization
Citations

This map shows the geographic impact of Yuri Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuri Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuri Yoshida more than expected).

Fields of papers citing papers by Yuri Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuri Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuri Yoshida. The network helps show where Yuri Yoshida may publish in the future.

Co-authorship network of co-authors of Yuri Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Yuri Yoshida. A scholar is included among the top collaborators of Yuri Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuri Yoshida. Yuri Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muro, Shigeo, Soichiro Hozawa, Hisatoshi Sugiura, et al.. (2025). Real-world effectiveness of budesonide/glycopyrronium/formoterol fumarate metered dose inhaler on symptoms and quality of life in patients with COPD: EBISU study. Respiratory Investigation. 63(5). 726–733. 1 indexed citations
2.
Kikuchi, Shinsuke, Kazuki Takahashi, Keisuke Kamada, et al.. (2025). Clinical Features of Acute on Chronic Lower Limb Ischemia and the Importance of Underlying Arterial Disease for Revascularization. Circulation Reports. 7(3). 168–175.
3.
Oka, Akihiko, Muyiwa Awoniyi, Yuri Yoshida, et al.. (2024). Dynamic ultrasonography for optimizing treatment position in superior mesenteric artery syndrome: Two case reports and review of literature. World Journal of Gastroenterology. 30(5). 499–508. 2 indexed citations
4.
5.
Kikuchi, Shinsuke, et al.. (2024). Super-Elderly Case of Acute Lower Limb Ischemia Treated with Indigo Aspiration System in Japan. Annals of Vascular Diseases. 17(1). 63–68. 1 indexed citations
6.
7.
Hashimoto, Shu, et al.. (2023). Real-World Evidence on the Diagnostic and Clinical Characteristics of Asthma in Japanese Patients with COPD: The ACO Japan Cohort Study. International Journal of COPD. Volume 18. 37–46. 9 indexed citations
8.
Saito‐Nakano, Yumiko, Chikako Shimokawa, Koichi Kobayashi, et al.. (2023). Prevalence and metronidazole resistance of Trichomonas vaginalis among Japanese women in 2021. IJID Regions. 7. 130–135. 2 indexed citations
9.
Oka, Akihiko, Yuri Yoshida, Hiroshi Tobita, et al.. (2023). EP129 SUPERIOR MESENTERIC ARTERY SYNDROME -A SYSTEMATIC REVIEW OF 2,453 CASES IN THE LITERATURE. Gastroenterology. 164(6). S–1215. 1 indexed citations
10.
11.
Oka, Akihiko, Muyiwa Awoniyi, Yuri Yoshida, et al.. (2023). Superior mesenteric artery syndrome: Diagnosis and management. World Journal of Clinical Cases. 11(15). 3369–3384. 31 indexed citations
12.
Teixeira, J. Pedro, Benjamin R. Griffin, Felipe González-Seguel, et al.. (2023). Critical illness myopathy and trajectory of recovery in acute kidney injury requiring continuous renal replacement therapy: a prospective observational trial protocol. BMJ Open. 13(5). e072448–e072448. 7 indexed citations
13.
Yoshida, Yuri, Maki Kabara, Jun Sawada, et al.. (2020). EphA7+ perivascular cells as myogenic and angiogenic precursors improving skeletal muscle regeneration in a muscular dystrophic mouse model. Stem Cell Research. 47. 101914–101914. 8 indexed citations
14.
Saito, Yukihiro, Shinsuke Kikuchi, Yuri Yoshida, et al.. (2019). Development of gene therapy with a cyclic adenosine monophosphate response element decoy oligodeoxynucleotide to prevent vascular intimal hyperplasia. Journal of Vascular Surgery. 71(1). 229–241. 5 indexed citations
15.
Kitahara, Hiroto, et al.. (2017). Papillary muscle rupture after myocardial infarction during left ventricular assist device support. Journal of Artificial Organs. 20(3). 263–265. 1 indexed citations
16.
Yoshida, Yuri, Shuichi Hokoi, & Daisuke Ogura. (2013). DEGRADATION OF A BIG BUDDHA IN SUKHOTHAI RUINS. Journal of Environmental Engineering (Transactions of AIJ). 78(689). 561–567. 2 indexed citations
17.
Yoshida, Yuri, Ryan L. Mizner, & Lynn Snyder‐Mackler. (2013). Association between long-term quadriceps weakness and early walking muscle co-contraction after total knee arthroplasty. The Knee. 20(6). 426–431. 32 indexed citations
18.
Yoshida, Yuri, Joseph Zeni, & Lynn Snyder‐Mackler. (2012). Do Patients Achieve Normal Gait Patterns 3 Years After Total Knee Arthroplasty?. Journal of Orthopaedic and Sports Physical Therapy. 42(12). 1039–1049. 59 indexed citations
19.
Yoshida, Yuri, Robin L. Marcus, & Paul C. LaStayo. (2012). Intramuscular adipose tissue and central activation in older adults. Muscle & Nerve. 46(5). 813–816. 72 indexed citations
20.
Yoshida, Yuri, Ryan L. Mizner, Dan K. Ramsey, & Lynn Snyder‐Mackler. (2007). Examining outcomes from total knee arthroplasty and the relationship between quadriceps strength and knee function over time. Clinical Biomechanics. 23(3). 320–328. 224 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lee Breakwell Breakdown of academic impact, for papers by Jayesh Trivedi Breakdown of academic impact, for papers by Lei Ma Breakdown of academic impact, for papers by Baoge Liu Breakdown of academic impact, for papers by Lea Niemitukia Breakdown of academic impact, for papers by Akinori Kaneguchi Breakdown of academic impact, for papers by Yoshimoto Ishikawa Breakdown of academic impact, for papers by P. Marks Breakdown of academic impact, for papers by Deniz Konya Breakdown of academic impact, for papers by Alice S. Ferng
Rankless by CCL
2026